Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia
NCT ID: NCT04352257
Last Updated: 2020-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2019-04-01
2021-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH
NCT07306767
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
NCT04853914
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
NCT05834270
The Influence of Benign Prostatic Hyperplasia on Bladder Function
NCT03098147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ultrasonography
pelvic and transrectal ultrasound
pelvic Ultrasound
pelvic and transrectal ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pelvic Ultrasound
pelvic and transrectal ultrasound
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kafrelsheikh University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diaa Eldin Taha Ramadan Mohamed
Lecturer of urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diaa Eldin Taha, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer of urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh faculty of medicine
Kafr ash Shaykh, Kafrelsheikh, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RS/19.21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.